BCAB – bioatla, inc. (US:NASDAQ)
Stock Stats
News
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors [Yahoo! Finance]
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors
BioAtla: A Buried ADC Concern Gets Some New Life In 2024 [Seeking Alpha]
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Form 4 BioAtla, Inc. For: Apr 30 Filed by: Smith Scott Andrew
Form 4 BioAtla, Inc. For: Apr 30 Filed by: Sievers Eric
Form 8-K BioAtla, Inc. For: Apr 22
Form ARS BioAtla, Inc. For: Dec 31
Form DEFA14A BioAtla, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.